Found 32 matching trials
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
PHASE2To evaluate the efficacy of SPD489 compared to placebo in the treatment of ...
Location
Clinical Study Centers, LLC
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
PHASE2To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Location
K&S Professional Research Services
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
PHASE4The purpose of this study is to determine effectiveness of Vyvanse compared...
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
PHASE3The purpose of this study is to evaluate the long-term safety of SPD489 adm...
Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder
PHASE4The primary objective of this study is to evaluate the maintenance of effic...
Location
Clinical Study Centers, LLC
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
PHASE3The primary objective of the study is to demonstrate the efficacy of SPD489...
Location
Radiant Research, Inc.
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
PHASE2To evaluate the efficacy of SPD489 for the treatment of executive function ...
Location
Sun Valley Research Center
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder
PHASE2The purpose of this study is to gain initial safety, tolerability, pharmaco...
Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia
PHASE1This is a multiple ascending dose study; the purpose of this study is to ex...
Location
California Clinical Trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
PHASE3To evaluate the safety and tolerability of SPD489 administered as a daily m...
Location
Birmingham Research Group